SIMILAR PATTERNS OF AMINO ACIDS FOR 4A9J_A_TYLA1188
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ciy | CRYIA(A) (Bacillusthuringiensis) |
PF00555(Endotoxin_M)PF03944(Endotoxin_C)PF03945(Endotoxin_N) | 4 | VAL A 160LEU A 148LEU A 157ILE A 97 | None | 0.93A | 4a9jA-1ciyA:0.7 | 4a9jA-1ciyA:13.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ddg | SULFITE REDUCTASE(NADPH) FLAVOPROTEINALPHA-COMPONENT (Escherichiacoli) |
PF00175(NAD_binding_1)PF00667(FAD_binding_1) | 4 | VAL A 437LEU A 268LEU A 263ILE A 390 | None | 0.89A | 4a9jA-1ddgA:0.0 | 4a9jA-1ddgA:16.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fps | FARNESYL DIPHOSPHATESYNTHASE (Gallus gallus) |
PF00348(polyprenyl_synt) | 4 | VAL A 285LEU A 300LEU A 199ASN A 279 | None | 0.96A | 4a9jA-1fpsA:0.6 | 4a9jA-1fpsA:17.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g61 | TRANSLATIONINITIATION FACTOR 6 (Methanocaldococcusjannaschii) |
PF01912(eIF-6) | 4 | VAL A2040LEU A2028LEU A2032ILE A2015 | None | 0.96A | 4a9jA-1g61A:undetectable | 4a9jA-1g61A:21.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kcz | BETA-METHYLASPARTASE (Clostridiumtetanomorphum) |
PF05034(MAAL_N)PF07476(MAAL_C) | 4 | VAL A 239LEU A 211LEU A 204ILE A 258 | None | 0.97A | 4a9jA-1kczA:0.3 | 4a9jA-1kczA:15.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kkr | 3-METHYLASPARTATEAMMONIA-LYASE (Citrobacteramalonaticus) |
PF05034(MAAL_N)PF07476(MAAL_C) | 4 | VAL A 239LEU A 211LEU A 204ILE A 258 | None | 0.95A | 4a9jA-1kkrA:undetectable | 4a9jA-1kkrA:16.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1lns | X-PROLYL DIPEPTIDYLAMINOPEPTIDASE (Lactococcuslactis) |
PF02129(Peptidase_S15)PF08530(PepX_C)PF09168(PepX_N) | 4 | VAL A 533LEU A 493LEU A 535ASN A 614 | None | 0.83A | 4a9jA-1lnsA:0.0 | 4a9jA-1lnsA:10.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1no5 | HYPOTHETICAL PROTEINHI0073 (Haemophilusinfluenzae) |
PF01909(NTP_transf_2) | 4 | VAL A 78LEU A 49LEU A 80ILE A 20 | None | 0.96A | 4a9jA-1no5A:undetectable | 4a9jA-1no5A:21.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qze | UV EXCISION REPAIRPROTEIN RAD23HOMOLOG A (Homo sapiens) |
PF00240(ubiquitin)PF00627(UBA)PF09280(XPC-binding) | 4 | VAL A 25LEU A 48LEU A 55ILE A 5 | None | 0.98A | 4a9jA-1qzeA:0.3 | 4a9jA-1qzeA:16.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1s3i | 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE (Rattusnorvegicus) |
PF00551(Formyl_trans_N)PF02911(Formyl_trans_C) | 4 | VAL A 289LEU A 279LEU A 287ILE A 211 | None | 0.93A | 4a9jA-1s3iA:undetectable | 4a9jA-1s3iA:18.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xnt | PROTEIN (DNA-REPAIRPROTEIN XRCC1) (Homo sapiens) |
PF01834(XRCC1_N) | 4 | VAL A 128LEU A 47LEU A 6ILE A 60 | None | 0.94A | 4a9jA-1xntA:undetectable | 4a9jA-1xntA:17.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zup | HYPOTHETICAL PROTEINTM1739 (Thermotogamaritima) |
PF09376(NurA) | 4 | VAL A 155LEU A 253LEU A 233ILE A 273 | None | 0.97A | 4a9jA-1zupA:undetectable | 4a9jA-1zupA:18.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2aa4 | PUTATIVEN-ACETYLMANNOSAMINEKINASE (Escherichiacoli) |
PF00480(ROK) | 4 | VAL A 253LEU A 268LEU A 250ILE A 127 | None | 0.88A | 4a9jA-2aa4A:undetectable | 4a9jA-2aa4A:18.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2aaz | THYMIDYLATE SYNTHASE (Cryptococcusneoformans) |
PF00303(Thymidylat_synt) | 4 | VAL A 302LEU A 280LEU A 63ILE A 77 | None | 0.82A | 4a9jA-2aazA:undetectable | 4a9jA-2aazA:15.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cb1 | O-ACETYL HOMOSERINESULFHYDRYLASE (Thermusthermophilus) |
PF01053(Cys_Met_Meta_PP) | 4 | VAL A 389LEU A 333LEU A 335ILE A 348 | None | 0.95A | 4a9jA-2cb1A:undetectable | 4a9jA-2cb1A:15.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2dvr | BROMODOMAIN-CONTAINING PROTEIN 2 (Homo sapiens) |
PF00439(Bromodomain) | 5 | VAL A 37LEU A 42LEU A 44ASN A 90ILE A 96 | None | 0.33A | 4a9jA-2dvrA:22.7 | 4a9jA-2dvrA:82.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2e0z | VIRUS-LIKE PARTICLE (Pyrococcusfuriosus) |
PF04454(Linocin_M18) | 4 | VAL A 204LEU A 130LEU A 134ILE A 294 | None | 0.94A | 4a9jA-2e0zA:undetectable | 4a9jA-2e0zA:16.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ewn | BIRA BIFUNCTIONALPROTEIN (Escherichiacoli) |
PF02237(BPL_C)PF03099(BPL_LplA_LipB)PF08279(HTH_11) | 4 | VAL A 169LEU A 179LEU A 184ILE A 231 | None | 0.95A | 4a9jA-2ewnA:undetectable | 4a9jA-2ewnA:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gv8 | MONOOXYGENASE (Schizosaccharomycespombe) |
PF00743(FMO-like)PF13450(NAD_binding_8) | 4 | VAL A 316LEU A 336ASN A 173ILE A 171 | None | 0.94A | 4a9jA-2gv8A:undetectable | 4a9jA-2gv8A:15.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2kzr | UBIQUITINTHIOESTERASE OTU1 (Mus musculus) |
no annotation | 4 | VAL A 3LEU A 17LEU A 61ILE A 30 | None | 0.91A | 4a9jA-2kzrA:undetectable | 4a9jA-2kzrA:19.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2l5e | BROMODOMAIN-CONTAINING PROTEIN 3 (Mus musculus) |
PF00439(Bromodomain) | 4 | LEU A 68LEU A 70ASN A 116ILE A 122 | None | 0.88A | 4a9jA-2l5eA:17.0 | 4a9jA-2l5eA:77.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ld7 | HISTONE DEACETYLASECOMPLEX SUBUNITSAP30PAIRED AMPHIPATHICHELIX PROTEIN SIN3A (Mus musculus) |
PF02671(PAH)PF13867(SAP30_Sin3_bdg) | 4 | VAL A 182LEU A 150LEU A 153ILE B 490 | None | 0.94A | 4a9jA-2ld7A:undetectable | 4a9jA-2ld7A:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ma9 | TRANSCRIPTIONELONGATION FACTOR BPOLYPEPTIDE 1VIRION INFECTIVITYFACTOR (Homo sapiens;Humanimmunodeficiencyvirus 1) |
PF00559(Vif)PF03931(Skp1_POZ) | 4 | VAL C 55LEU C 85LEU A 8ILE C 47 | None | 0.96A | 4a9jA-2ma9C:undetectable | 4a9jA-2ma9C:23.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mbg | RALA-BINDING PROTEIN1 (Homo sapiens) |
PF00620(RhoGAP) | 4 | VAL A 350LEU A 278LEU A 279ILE A 322 | None | 0.59A | 4a9jA-2mbgA:undetectable | 4a9jA-2mbgA:20.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mlb | REDESIGNED UBIQUITIN (syntheticconstruct) |
PF00240(ubiquitin) | 4 | VAL A 18LEU A 27LEU A 57ILE A 68 | None | 0.78A | 4a9jA-2mlbA:undetectable | 4a9jA-2mlbA:18.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2o6q | VARIABLE LYMPHOCYTERECEPTOR A (Eptatretusburgeri) |
PF13855(LRR_8) | 4 | VAL A 114LEU A 95LEU A 119ILE A 102 | None | 0.97A | 4a9jA-2o6qA:undetectable | 4a9jA-2o6qA:22.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2owo | DNA LIGASE (Escherichiacoli) |
PF01653(DNA_ligase_aden)PF03119(DNA_ligase_ZBD)PF03120(DNA_ligase_OB)PF12826(HHH_2)PF14520(HHH_5) | 4 | VAL A 444LEU A 474LEU A 500ILE A 458 | None | 0.81A | 4a9jA-2owoA:undetectable | 4a9jA-2owoA:12.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p2s | PUTATIVEOXIDOREDUCTASE (Pectobacteriumatrosepticum) |
PF01408(GFO_IDH_MocA)PF02894(GFO_IDH_MocA_C) | 4 | VAL A 108LEU A 105LEU A 99ILE A 317 | None | 0.97A | 4a9jA-2p2sA:undetectable | 4a9jA-2p2sA:18.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qgi | ATP SYNTHASESUBUNITS REGION ORF6 (Rhodobacterblasticus) |
no annotation | 4 | VAL A 85LEU A 200LEU A 87ILE A 79 | None | 0.97A | 4a9jA-2qgiA:undetectable | 4a9jA-2qgiA:16.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qtz | METHIONINE SYNTHASEREDUCTASE (Homo sapiens) |
PF00175(NAD_binding_1)PF00667(FAD_binding_1) | 4 | VAL A 469LEU A 295LEU A 284ILE A 553 | None | 0.91A | 4a9jA-2qtzA:undetectable | 4a9jA-2qtzA:14.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vgq | SUGAR ABCTRANSPORTERSUBSTRATE-BINDINGPROTEIN,MITOCHONDRIALANTIVIRAL-SIGNALINGPROTEIN (Escherichiacoli;Homo sapiens) |
PF13416(SBP_bac_8)PF16739(CARD_2) | 4 | VAL A 391LEU A 453LEU A 445ILE A 381 | None | 0.65A | 4a9jA-2vgqA:undetectable | 4a9jA-2vgqA:16.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2wp1 | BROMODOMAINTESTIS-SPECIFICPROTEIN (Mus musculus) |
PF00439(Bromodomain) | 4 | VAL A 298LEU A 303LEU A 305ASN A 351 | None | 0.41A | 4a9jA-2wp1A:18.2 | 4a9jA-2wp1A:35.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yb5 | PUTATIVE FUSIDICACID RESISTANCEPROTEIN (Staphylococcusaureus) |
PF07299(EF-G-binding_N)PF16571(FBP_C) | 4 | VAL A 12LEU A 74LEU A 77ILE A 60 | None | 0.87A | 4a9jA-2yb5A:undetectable | 4a9jA-2yb5A:22.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2yek | BROMODOMAIN-CONTAINING PROTEIN 2 (Homo sapiens) |
PF00439(Bromodomain) | 5 | VAL A 103LEU A 108LEU A 110ASN A 156ILE A 162 | EAM A1188 (-4.4A)EAM A1188 ( 3.8A)EAM A1188 (-4.5A)EAM A1188 (-3.2A)EAM A1188 (-3.8A) | 0.40A | 4a9jA-2yekA:23.3 | 4a9jA-2yekA:99.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cdk | SUCCINYL-COA:3-KETOACID-COENZYME ATRANSFERASE SUBUNITA (Bacillussubtilis) |
PF01144(CoA_trans) | 4 | VAL A 51LEU A 63LEU A 66ILE A 155 | None | 0.90A | 4a9jA-3cdkA:undetectable | 4a9jA-3cdkA:18.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctz | XAA-PROAMINOPEPTIDASE 1 (Homo sapiens) |
PF00557(Peptidase_M24)PF01321(Creatinase_N)PF16188(Peptidase_M24_C)PF16189(Creatinase_N_2) | 4 | VAL A 247LEU A 251LEU A 253ILE A 237 | None | 0.73A | 4a9jA-3ctzA:undetectable | 4a9jA-3ctzA:13.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dls | PASDOMAIN-CONTAININGSERINE/THREONINE-PROTEIN KINASE (Homo sapiens) |
PF00069(Pkinase) | 4 | VAL A1265LEU A1104LEU A1100ILE A1136 | None | 0.94A | 4a9jA-3dlsA:undetectable | 4a9jA-3dlsA:20.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dpt | RAB FAMILY PROTEIN (Chlorobaculumtepidum) |
PF16095(COR) | 4 | VAL A 695LEU A 673LEU A 676ILE A 657 | None | 0.96A | 4a9jA-3dptA:undetectable | 4a9jA-3dptA:15.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dpu | RAB FAMILY PROTEIN (Chlorobaculumtepidum) |
PF08477(Roc)PF16095(COR) | 4 | VAL A 695LEU A 673LEU A 676ILE A 657 | None | 0.97A | 4a9jA-3dpuA:undetectable | 4a9jA-3dpuA:13.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3e4w | PUTATIVEUNCHARACTERIZEDPROTEIN (Mycobacteriumavium) |
PF00199(Catalase) | 4 | VAL A 219LEU A 214LEU A 210ILE A 62 | None | 0.97A | 4a9jA-3e4wA:undetectable | 4a9jA-3e4wA:19.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3egw | RESPIRATORY NITRATEREDUCTASE 1 ALPHACHAIN (Escherichiacoli) |
PF00384(Molybdopterin)PF01568(Molydop_binding)PF14710(Nitr_red_alph_N) | 4 | VAL A 769LEU A 786LEU A 771ILE A 829 | NoneNoneMD1 A1245 (-4.2A)None | 0.90A | 4a9jA-3egwA:undetectable | 4a9jA-3egwA:7.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fcp | L-ALA-D/L-GLUEPIMERASE, AMUCONATE LACTONIZINGENZYME (Klebsiellapneumoniae) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 4 | VAL A 253LEU A 287LEU A 273ILE A 296 | None | 0.96A | 4a9jA-3fcpA:undetectable | 4a9jA-3fcpA:16.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fhc | ATP-DEPENDENT RNAHELICASE DDX19B (Homo sapiens) |
PF00270(DEAD) | 4 | VAL B 288LEU B 241LEU B 272ILE B 248 | None | 0.97A | 4a9jA-3fhcB:undetectable | 4a9jA-3fhcB:19.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3k2k | PUTATIVECARBOXYPEPTIDASE (Burkholderiamallei) |
PF00246(Peptidase_M14) | 4 | VAL A 212LEU A 148LEU A 137ILE A 256 | None | 0.84A | 4a9jA-3k2kA:undetectable | 4a9jA-3k2kA:18.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3k8i | 30KLP (Treponemapallidum) |
no annotation | 4 | VAL A 187LEU A 48LEU A 189ILE A 277 | None | 0.88A | 4a9jA-3k8iA:undetectable | 4a9jA-3k8iA:17.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lq1 | 2-SUCCINYL-5-ENOLPYRUVYL-6-HYDROXY-3-CYCLOHEXENE-1-CARBOXYLATE SYNTHASE (Listeriamonocytogenes) |
PF02775(TPP_enzyme_C)PF02776(TPP_enzyme_N)PF16582(TPP_enzyme_M_2) | 4 | VAL A 75LEU A 104LEU A 77ILE A 16 | None | 0.81A | 4a9jA-3lq1A:undetectable | 4a9jA-3lq1A:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3oc6 | 6-PHOSPHOGLUCONOLACTONASE (Mycolicibacteriumsmegmatis) |
PF01182(Glucosamine_iso) | 4 | VAL A 54LEU A 51LEU A 50ILE A 39 | None | 0.90A | 4a9jA-3oc6A:undetectable | 4a9jA-3oc6A:18.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3oc6 | 6-PHOSPHOGLUCONOLACTONASE (Mycolicibacteriumsmegmatis) |
PF01182(Glucosamine_iso) | 4 | VAL A 54LEU A 92LEU A 51ILE A 39 | None | 0.94A | 4a9jA-3oc6A:undetectable | 4a9jA-3oc6A:18.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3oep | PUTATIVEUNCHARACTERIZEDPROTEIN TTHA0988 (Thermusthermophilus) |
PF02626(CT_A_B)PF02682(CT_C_D) | 4 | VAL A 445LEU A 408LEU A 394ILE A 489 | None | 0.95A | 4a9jA-3oepA:undetectable | 4a9jA-3oepA:12.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pr6 | TRAPP-ASSOCIATEDPROTEIN TCA17 (Saccharomycescerevisiae) |
PF04628(Sedlin_N) | 4 | VAL A 8LEU A 10LEU A 19ILE A 115 | None | 0.94A | 4a9jA-3pr6A:undetectable | 4a9jA-3pr6A:19.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3psh | PROTEIN HI_1472 (Haemophilusinfluenzae) |
PF01497(Peripla_BP_2) | 4 | VAL A 251LEU A 248LEU A 214ILE A 272 | None | 0.89A | 4a9jA-3pshA:undetectable | 4a9jA-3pshA:17.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rr1 | PUTATIVED-GALACTONATEDEHYDRATASE (Ralstoniapickettii) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 4 | VAL A 102LEU A 105LEU A 106ILE A 60 | None | 0.96A | 4a9jA-3rr1A:undetectable | 4a9jA-3rr1A:18.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tsn | 4-HYDROXYTHREONINE-4-PHOSPHATEDEHYDROGENASE (Campylobacterjejuni) |
PF04166(PdxA) | 4 | VAL A 20LEU A 52LEU A 45ILE A 36 | None | 0.92A | 4a9jA-3tsnA:undetectable | 4a9jA-3tsnA:15.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ttl | POLYAMINE TRANSPORTPROTEIN (Pseudomonasaeruginosa) |
PF13416(SBP_bac_8) | 4 | VAL A 128LEU A 98LEU A 103ILE A 78 | None | 0.83A | 4a9jA-3ttlA:undetectable | 4a9jA-3ttlA:19.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zgk | AVR3A11 (Phytophthoracapsici) |
PF16810(RXLR) | 4 | VAL A 75LEU A 110LEU A 106ILE A 82 | None | 0.87A | 4a9jA-3zgkA:undetectable | 4a9jA-3zgkA:16.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b6j | PHOSPHOSERINEPHOSPHATASE (Thermococcusonnurineus) |
PF12710(HAD) | 4 | VAL A 168LEU A 185LEU A 182ILE A 7 | None | 0.98A | 4a9jA-4b6jA:undetectable | 4a9jA-4b6jA:18.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b6z | FAMILY M14UNASSIGNED PEPTIDASE (Burkholderiacenocepacia) |
PF00246(Peptidase_M14) | 4 | VAL A 212LEU A 148LEU A 137ILE A 256 | None | 0.82A | 4a9jA-4b6zA:undetectable | 4a9jA-4b6zA:18.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fbq | DNA REPAIR ANDTELOMERE MAINTENANCEPROTEIN NBS1,DNAREPAIR PROTEIN RAD32CHIMERIC PROTEIN (Schizosaccharomycespombe) |
PF00149(Metallophos)PF04152(Mre11_DNA_bind) | 4 | VAL A1127LEU A1084LEU A1049ILE A1066 | None | 0.83A | 4a9jA-4fbqA:undetectable | 4a9jA-4fbqA:15.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fcx | DNA REPAIR PROTEINRAD32 (Schizosaccharomycespombe) |
no annotation | 4 | VAL B 127LEU B 84LEU B 49ILE B 66 | None | 0.82A | 4a9jA-4fcxB:undetectable | 4a9jA-4fcxB:15.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fmz | INTERNALIN (Listeriamonocytogenes) |
PF12354(Internalin_N)PF12799(LRR_4)PF13855(LRR_8) | 4 | VAL A 294LEU A 281LEU A 303ILE A 288 | None | 0.93A | 4a9jA-4fmzA:undetectable | 4a9jA-4fmzA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fva | 5'-TYROSYL-DNAPHOSPHODIESTERASE (Caenorhabditiselegans) |
PF03372(Exo_endo_phos) | 4 | VAL A 146LEU A 154LEU A 190ILE A 127 | None | 0.92A | 4a9jA-4fvaA:undetectable | 4a9jA-4fvaA:18.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g9k | ROTENONE-INSENSITIVENADH-UBIQUINONEOXIDOREDUCTASE (Saccharomycescerevisiae) |
PF07992(Pyr_redox_2) | 4 | VAL A 147LEU A 157LEU A 159ILE A 167 | VAL A 147 ( 0.6A)LEU A 157 ( 0.6A)LEU A 159 ( 0.6A)ILE A 167 ( 0.7A) | 0.82A | 4a9jA-4g9kA:undetectable | 4a9jA-4g9kA:15.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gew | 5'-TYROSYL-DNAPHOSPHODIESTERASE (Caenorhabditiselegans) |
PF03372(Exo_endo_phos)PF14555(UBA_4) | 4 | VAL A 146LEU A 154LEU A 190ILE A 127 | None | 0.94A | 4a9jA-4gewA:undetectable | 4a9jA-4gewA:17.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4glx | DNA LIGASE (Escherichiacoli) |
PF01653(DNA_ligase_aden)PF03119(DNA_ligase_ZBD)PF03120(DNA_ligase_OB)PF12826(HHH_2)PF14520(HHH_5) | 4 | VAL A 444LEU A 474LEU A 500ILE A 458 | None | 0.76A | 4a9jA-4glxA:undetectable | 4a9jA-4glxA:13.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hbx | BROMODOMAIN-CONTAINING PROTEIN 4 (Homo sapiens) |
PF00439(Bromodomain) | 5 | VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146 | 14X A 201 (-4.7A)14X A 201 (-4.4A)None14X A 201 (-3.1A)14X A 201 ( 4.0A) | 0.38A | 4a9jA-4hbxA:20.5 | 4a9jA-4hbxA:70.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hhr | ALPHA-DIOXYGENASE (Arabidopsisthaliana) |
PF03098(An_peroxidase) | 4 | VAL A 477LEU A 482LEU A 479ASN A 267 | NoneHEM A 701 (-4.5A)HEM A 701 (-4.5A)HEM A 701 ( 3.4A) | 0.93A | 4a9jA-4hhrA:2.8 | 4a9jA-4hhrA:12.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hse | CHAPERONE PROTEINCLPB (Thermusthermophilus) |
PF00004(AAA) | 4 | VAL A 254LEU A 251LEU A 237ILE A 269 | None | 0.98A | 4a9jA-4hseA:2.3 | 4a9jA-4hseA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4i0o | PROTEIN ELYS (Mus musculus) |
PF16687(ELYS-bb) | 4 | VAL A 197LEU A 211LEU A 152ILE A 193 | None | 0.98A | 4a9jA-4i0oA:undetectable | 4a9jA-4i0oA:14.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k0e | HEAVY METAL CATIONTRICOMPONENT EFFLUXPUMP ZNEA(CZCA-LIKE) (Cupriavidusmetallidurans) |
PF00873(ACR_tran) | 4 | VAL A 50LEU A 92LEU A 90ASN A 597 | None | 0.95A | 4a9jA-4k0eA:2.1 | 4a9jA-4k0eA:9.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qpc | 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE (Danio rerio) |
PF00551(Formyl_trans_N)PF02911(Formyl_trans_C) | 4 | VAL A 290LEU A 280LEU A 288ILE A 211 | None | 0.95A | 4a9jA-4qpcA:undetectable | 4a9jA-4qpcA:18.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4tkm | NADH-DEPENDENTREDUCTASE FOR4-DEOXY-L-ERYTHRO-5-HEXOSEULOSE URONATE (Sphingomonassp. A1) |
PF13561(adh_short_C2) | 4 | VAL A 76LEU A 11LEU A 89ILE A 66 | None | 0.86A | 4a9jA-4tkmA:undetectable | 4a9jA-4tkmA:17.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homo sapiens) |
PF00439(Bromodomain) | 5 | VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146 | V1T A1171 (-4.9A)V1T A1171 (-3.8A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A) | 0.38A | 4a9jA-4uydA:20.5 | 4a9jA-4uydA:71.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4uyg | BROMODOMAIN-CONTAINING PROTEIN 2 (Homo sapiens) |
PF00439(Bromodomain) | 4 | VAL A 376LEU A 381LEU A 383ASN A 429 | 73B A1456 (-4.0A)73B A1456 (-4.9A)73B A1456 (-4.9A)73B A1456 (-3.3A) | 0.34A | 4a9jA-4uygA:19.3 | 4a9jA-4uygA:48.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4w8j | PESTICIDAL CRYSTALPROTEIN CRY1AC (Bacillusthuringiensis) |
PF00555(Endotoxin_M)PF03944(Endotoxin_C)PF03945(Endotoxin_N) | 4 | VAL A 160LEU A 148LEU A 157ILE A 97 | None | 0.83A | 4a9jA-4w8jA:2.8 | 4a9jA-4w8jA:10.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xzg | HELICASE-LIKETRANSCRIPTION FACTOR (Homo sapiens) |
PF08797(HIRAN) | 4 | VAL A 160LEU A 164LEU A 171ILE A 130 | None | 0.95A | 4a9jA-4xzgA:undetectable | 4a9jA-4xzgA:26.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4z93 | BROMODOMAIN-CONTAINING PROTEIN 4 (Homo sapiens) |
PF00439(Bromodomain) | 4 | VAL A 380LEU A 385LEU A 387ASN A 433 | 4LD A 501 ( 3.8A)4LD A 501 (-4.1A)4LD A 501 (-4.4A)4LD A 501 (-2.8A) | 0.24A | 4a9jA-4z93A:19.1 | 4a9jA-4z93A:37.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zke | SUPERKILLER PROTEIN7 (Saccharomycescerevisiae) |
PF00009(GTP_EFTU) | 4 | VAL A 708LEU A 687LEU A 674ILE A 659 | VAL A 708 ( 0.6A)LEU A 687 ( 0.6A)LEU A 674 ( 0.6A)ILE A 659 ( 0.7A) | 0.78A | 4a9jA-4zkeA:undetectable | 4a9jA-4zkeA:15.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hjc | BROMODOMAIN-CONTAINING PROTEIN 3 (Homo sapiens) |
PF00439(Bromodomain) | 4 | VAL A 338LEU A 343LEU A 345ASN A 391 | None | 0.34A | 4a9jA-5hjcA:19.2 | 4a9jA-5hjcA:37.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hqb | ALPHA-GLUCOSIDASE (Pseudoalteromonassp. K8) |
PF10566(Glyco_hydro_97)PF14508(GH97_N)PF14509(GH97_C) | 4 | VAL A 657LEU A 621LEU A 624ILE A 675 | None | 0.89A | 4a9jA-5hqbA:undetectable | 4a9jA-5hqbA:13.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5huu | ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTHASE[UDP-FORMING] (Candidaalbicans) |
PF00982(Glyco_transf_20) | 4 | VAL A 9LEU A 146LEU A 149ILE A 78 | None | 0.85A | 4a9jA-5huuA:undetectable | 4a9jA-5huuA:13.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hxd | PROTEIN MPAA (Escherichiacoli) |
PF00246(Peptidase_M14) | 4 | VAL A 3LEU A 70LEU A 66ASN A 229 | None | 0.97A | 4a9jA-5hxdA:undetectable | 4a9jA-5hxdA:18.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hxg | UNCHARACTERIZEDPROTEIN STM1697 (Salmonellaenterica) |
PF00563(EAL) | 4 | VAL A 101LEU A 95LEU A 56ILE A 77 | None | 0.97A | 4a9jA-5hxgA:undetectable | 4a9jA-5hxgA:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ido | 3' TERMINAL URIDYLYLTRANSFERASE (Trypanosomabrucei) |
PF03828(PAP_assoc) | 4 | VAL A 283LEU A 280LEU A 467ILE A 362 | None | 0.96A | 4a9jA-5idoA:undetectable | 4a9jA-5idoA:13.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lc5 | NADH DEHYDROGENASE[UBIQUINONE]IRON-SULFUR PROTEIN2, MITOCHONDRIAL (Bos taurus) |
PF00346(Complex1_49kDa) | 4 | VAL D 184LEU D 207LEU D 203ILE D 144 | None | 0.74A | 4a9jA-5lc5D:undetectable | 4a9jA-5lc5D:16.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5n15 | BROMODOMAIN-CONTAINING FACTOR 1 (Candidaalbicans) |
PF00439(Bromodomain) | 4 | VAL A 238LEU A 243ASN A 291ILE A 297 | NoneNoneIOD A 404 (-3.9A)IOD A 404 ( 4.8A) | 0.41A | 4a9jA-5n15A:16.9 | 4a9jA-5n15A:31.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 4 | VAL A 939LEU A 941LEU A 901ILE A 885 | CSO A 938 ( 2.8A)NoneNoneNone | 0.90A | 4a9jA-5nn8A:undetectable | 4a9jA-5nn8A:10.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nph | HEAVY CHAIN OF FABFRAGMENT DERIVEDFROMNON-NEUTRALIZINGANTIBODY DAO5 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 116LEU H 18LEU H 86ILE H 81 | None | 0.90A | 4a9jA-5nphH:undetectable | 4a9jA-5nphH:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5npi | SINGLE CHAINVARIABLE FRAGMENT OFTHE NON-NEUTRALIZINGANTIBODY DAO5 (Mus musculus) |
PF07686(V-set) | 4 | VAL A 116LEU A 18LEU A 86ILE A 81 | None | 0.85A | 4a9jA-5npiA:undetectable | 4a9jA-5npiA:15.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nxk | SERINE-RICH SECRETEDCELL WALL ANCHORED(LPXTG-MOTIF )PROTEIN (Lactobacillusreuteri) |
no annotation | 4 | VAL A 534LEU A 536LEU A 562ILE A 526 | None | 0.94A | 4a9jA-5nxkA:undetectable | 4a9jA-5nxkA:19.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5opt | RIBOSOMAL PROTEINS7, PUTATIVE (Trypanosomacruzi) |
no annotation | 4 | VAL Q 76LEU Q 83LEU Q 98ASN Q 49 | None | 0.77A | 4a9jA-5optQ:undetectable | 4a9jA-5optQ:21.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5u6v | BROMODOMAIN-CONTAINING PROTEIN 2 (Homo sapiens) |
no annotation | 4 | VAL A 376LEU A 381LEU A 383ASN A 429 | 7WY A 501 ( 4.5A)7WY A 501 (-4.9A)None7WY A 501 (-3.4A) | 0.39A | 4a9jA-5u6vA:19.2 | 4a9jA-5u6vA:39.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u9n | BROMO DOMAINCONTAINING PROTEIN (Cryptosporidiumparvum) |
PF00439(Bromodomain) | 4 | VAL A 332LEU A 338ASN A 413ILE A 422 | BMF A 501 (-4.2A)BMF A 501 ( 4.9A)BMF A 501 (-2.8A)BMF A 501 ( 4.4A) | 0.84A | 4a9jA-5u9nA:15.4 | 4a9jA-5u9nA:20.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uj8 | ORIGIN RECOGNITIONCOMPLEX SUBUNIT 3 (Homo sapiens) |
PF07034(ORC3_N) | 4 | VAL A 288LEU A 292LEU A 293ILE A 325 | None | 0.97A | 4a9jA-5uj8A:undetectable | 4a9jA-5uj8A:11.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v6b | PDZDOMAIN-CONTAININGPROTEIN GIPC1 (Mus musculus) |
PF00595(PDZ) | 4 | VAL A 134LEU A 209LEU A 211ILE A 166 | None | 0.84A | 4a9jA-5v6bA:undetectable | 4a9jA-5v6bA:18.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vbr | BROMODOMAINTESTIS-SPECIFICPROTEIN (Homo sapiens) |
no annotation | 5 | VAL A 56LEU A 61LEU A 63ASN A 109ILE A 115 | IBI A 201 ( 4.6A)IBI A 201 (-4.2A)IBI A 201 (-4.9A)IBI A 201 (-3.3A)IBI A 201 ( 3.8A) | 0.76A | 4a9jA-5vbrA:20.2 | 4a9jA-5vbrA:55.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xog | RNA POLYMERASE IITHIRD LARGESTSUBUNIT B44, PART OFCENTRAL CORE (Komagataellaphaffii) |
PF01000(RNA_pol_A_bac)PF01193(RNA_pol_L) | 4 | VAL C 7LEU C 21LEU C 19ILE C 248 | None | 0.94A | 4a9jA-5xogC:undetectable | 4a9jA-5xogC:16.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5zln | TOLL-LIKE RECEPTOR 9 (Mus musculus) |
no annotation | 4 | VAL A 420LEU A 398LEU A 422ILE A 410 | None | 0.97A | 4a9jA-5zlnA:undetectable | 4a9jA-5zlnA:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ams | BETA SLIDING CLAMP (Pseudomonasaeruginosa) |
no annotation | 4 | VAL A 37LEU A 42LEU A 59ILE A 90 | None | 0.93A | 4a9jA-6amsA:undetectable | 4a9jA-6amsA:16.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cw0 | CGD2_2690 PROTEIN (Cryptosporidiumparvum) |
no annotation | 4 | VAL A 30LEU A 35LEU A 37ASN A 83 | R78 A 201 (-4.5A)R78 A 201 (-4.9A)NoneR78 A 201 (-3.3A) | 0.64A | 4a9jA-6cw0A:17.5 | 4a9jA-6cw0A:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6dne | BROMODOMAIN-CONTAINING PROTEIN 4 (Homo sapiens) |
no annotation | 5 | VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146 | H1V A 501 ( 4.4A)H1V A 501 (-4.2A)H1V A 501 (-4.7A)H1V A 501 (-3.2A)H1V A 501 (-3.8A) | 0.49A | 4a9jA-6dneA:20.0 | 4a9jA-6dneA:undetectable |